ArticleBMC microbiology2026
The effect of biochanin A on the antibiotic susceptibilities of Escherichia coli grown under different respiration and metabolic conditions on agar media.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundAntimicrobials have been used for a number of purposes in beef cattle production. However, increased prevalence of pathogens, including zoonotic bacterial species, such as Escherichia coli, is a concern. The flavonoid, biochanin A (BCA), was identified as a natural feed component to potentially limit the spread of antibiotic-resistant microorganisms by potentiating the activity of other antimicrobials. The current study investigated the synergistic effects of 120 ppm BCA with five classes of antibiotics on two strains of E. coli: 25922 and 51659 (O157:H7) on two agar culture media by using commercially available ETEST® strips and the FDA/CLSI breakpoint interpretation criteria.
resultsThe effect of 120 ppm BCA on minimum inhibitory concentration (MIC) across the antibiotic classes was relatively consistent where it had largely no effect, an occasionally negative effect, or a neutral effect. BCA addition yielded negligible changes to ciprofloxacin (susceptible) for either strain under the redox and metabolic conditions tested. The culture conditions seemed more influential over MIC than BCA. The absence of oxygen generally conferred clinical resistance or a higher MIC, and at times media composition altered the MICs as well. For example, neither macrolide inhibited either strain (> 256 µg mL− 1) under anaerobic conditions but generally had measurable MICs aerobically. Additionally, the MICs for streptomycin were consistently higher across each strain when cultured on tryptic soy agar rather than Mueller Hinton broth.
conclusionsDespite previous studies in which biochanin A decreased MICs in other bacterial species, neither strain of E. coli was consistently impacted by the presence of 120 ppm BCA in the culture medium. The data indicate that BCA is likely not a reliable resensitizing/synergistic candidate for resistant E. coli. Regardless, the data demonstrates the impact culture conditions have on MIC across antibiotic class. These differences in susceptibility may be necessary to consider when treating E. coli infections under different conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.